Medicine
Odefsey 200 mg/25 mg/25 mg tablet
Odefsey 200 mg/25 mg/25 mg tablet is a prescription medicine containing Emtricitabine, Rilpivirine and Tenofovir alafenamide for oral use, marketed by Gilead Sciences, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store below 30°C (86°F).
Key facts
- Active ingredient (INN)
- Emtricitabine, Rilpivirine and Tenofovir alafenamide
- Brand
- Odefsey
- Strength
- 200 mg/25 mg/25 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets
- Marketing authorisation holder
- Gilead Sciences
- Manufacturer
- Gilead Sciences
- Origin register
- US FDA, United States
- Storage
- Store below 30°C (86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AR19 Emtricitabine, Rilpivirine and Tenofovir alafenamide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 March 2016
- Identifiers
- RxCUI 1741733, 1741739DailyMed set ID ea3b9ec8-e04a-412c-8b3f-e5cbc7e641d5NDC 61958-2101Application NDA208351
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle, plastic | 61958-2101-1 | Gilead Sciences | 1 March 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Emtricitabine, Rilpivirine and Tenofovir alafenamide is a fixed-dose combination of a human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor, a hepatitis B virus nucleoside analog reverse transcriptase inhibitor and a human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor. MedsAcross supplies Emtricitabine, Rilpivirine and Tenofovir alafenamide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Emtricitabine, Rilpivirine and Tenofovir alafenamideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ODEFSEY prescribing information (Gilead Sciences) · U.S. National Library of Medicine, DailyMed
- Odefsey: European public assessment report (EPAR) · European Medicines Agency
- Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris: European public assessment report (EPAR) · European Medicines Agency
Need Odefsey 200 mg/25 mg/25 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.